Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP528320.RA9bXvQFtAzTAQaYyc6SSYAU1m-ZzCu9aB34OsLulQeA4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP528320.RA9bXvQFtAzTAQaYyc6SSYAU1m-ZzCu9aB34OsLulQeA4130_assertion type Assertion NP528320.RA9bXvQFtAzTAQaYyc6SSYAU1m-ZzCu9aB34OsLulQeA4130_head.
- NP528320.RA9bXvQFtAzTAQaYyc6SSYAU1m-ZzCu9aB34OsLulQeA4130_assertion description "[What's more, the levels of BMI-1 autoantibody increased significantly at stage I (0.672�0.019) compared to normal sera (P<0.001), and levels of BMI-1 autoantibodies were increased gradually during the tumor progression (stage I 0.672�0.019; stage II 0.775 �0.019; stage III 0.890 �0.027; stage IV 1.043�0.041), which were significantly correlated with disease progression of cervical cancer (P<0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP528320.RA9bXvQFtAzTAQaYyc6SSYAU1m-ZzCu9aB34OsLulQeA4130_provenance.
- NP528320.RA9bXvQFtAzTAQaYyc6SSYAU1m-ZzCu9aB34OsLulQeA4130_assertion evidence source_evidence_literature NP528320.RA9bXvQFtAzTAQaYyc6SSYAU1m-ZzCu9aB34OsLulQeA4130_provenance.
- NP528320.RA9bXvQFtAzTAQaYyc6SSYAU1m-ZzCu9aB34OsLulQeA4130_assertion SIO_000772 22132147 NP528320.RA9bXvQFtAzTAQaYyc6SSYAU1m-ZzCu9aB34OsLulQeA4130_provenance.
- NP528320.RA9bXvQFtAzTAQaYyc6SSYAU1m-ZzCu9aB34OsLulQeA4130_assertion wasDerivedFrom befree-20140225 NP528320.RA9bXvQFtAzTAQaYyc6SSYAU1m-ZzCu9aB34OsLulQeA4130_provenance.
- NP528320.RA9bXvQFtAzTAQaYyc6SSYAU1m-ZzCu9aB34OsLulQeA4130_assertion wasGeneratedBy ECO_0000203 NP528320.RA9bXvQFtAzTAQaYyc6SSYAU1m-ZzCu9aB34OsLulQeA4130_provenance.